Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.
Saved in:
| Title: | Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study. |
|---|---|
| Authors: | Büttner T; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany., Rizzo M; Division of Medical Oncology, Azienda Ospedaliera Universitaria Consorziale - Policlinico di Bari, Bari, Italy. rizzo.mimma@gmail.com., Bernal Vaca L; Servicio de Oncología, Clínica Universitaria Colombia - Clínica de Marly, Bogotá, Colombia., Molina-Cerrillo J; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Alonso-Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Juárez A; Department of Urology, Jerez University Hospital, Jerez, Spain., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint Luc, Brussel, Belgium., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Gandur Quiroga MN; Division of Genitourinary Medical Oncology, Instituto de Oncologia Ángel H. Roffo, Buenos Aires, Argentina., Bourlon MT; Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Bögemann M; Department of Urology, University Hospital Münster, Münster, Germany.; West German Cancer Center, Münster, Germany., Kopecky J; Department of Clinical Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Rescigno P; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, Barcelona, Spain., Myint ZW; Division of Medical Oncology, Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Ürün Y; Medical Oncology, Ankara University Medical Faculty, Ankara, Türkiye., Scagliarini S; Department of Medical Oncology, AORN 'A. Cardarelli', Naples, Italy., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Matthews D; Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff, Wales., Li H; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, Westwood, KS, USA., Rizzo A; S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Mosca A; Oncology Department, Candiolo Cancer Institute, IRCCS-FPO, Torino, Italy., Lenci E; Medical Oncology Unit, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy., Melichar B; Department of Oncology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic., Wenzel M; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Mandell P; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Antonarakis ES; University of Minnesota, Masonic Cancer Center, Minneapolis, MN, USA., Santoni M; Medical Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2026 Jan 08. Date of Electronic Publication: 2026 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!